chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacy technician refers to a 2 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 28-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
Caller stated that she was contacted by Sherriff department that father called  911. When ambulance arrived they did CPR.  When they  took him to the hospital they perform CPR again.  Father was pronounced dead at 1am.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included PREDNISONE for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced MYALGIA (Sore arm). At the time of the report, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Ischemic CVA and N-STEMI type 2 cardiac event 5 days post injection.  Dizziness and left-sided weakness.  Admitted to hospital, transferred to rehab unit on day 3, discharged home day 8.
Chills were the first symptom. The next day, I also experienced feeling very cold and some chills. I passed out briefly after getting out of bed and threw up right after that. I had body aches. I was nauseous but was able to take ibuprofen in the late morning.  After the ibuprofen wore off, my body aches returned as well as a lethargic feeling. The next morning, I experienced nausea again until in the afternoon.
pain and soreness in arm and shoulder; pain and soreness in arm and shoulder; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (pain and soreness in arm and shoulder) and ARTHRALGIA (pain and soreness in arm and shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain and soreness in arm and shoulder) and ARTHRALGIA (pain and soreness in arm and shoulder). At the time of the report, PAIN IN EXTREMITY (pain and soreness in arm and shoulder) and ARTHRALGIA (pain and soreness in arm and shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pericardial effusion; short of breath; I cannot walk thru a grocery store; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed; unknown manufacturer), for COVID-19 immunization.  The following information was reported: PERICARDIAL EFFUSION (medically significant), outcome "unknown"; DYSPNOEA (non-serious), outcome "unknown", described as "short of breath"; GAIT INABILITY (non-serious), outcome "unknown", described as "I cannot walk thru a grocery store". The patient underwent the following laboratory tests and procedures: Catheterisation cardiac: (19Dec2022) No results provided. Therapeutic measures were taken as a result of pericardial effusion.  Clinical course: A few weeks after the patient received the booster, the patient became short of breath. I cannot walk thru a grocery store patient had a heart cath on 19Dec2022 and patient have pericardial effusion trying to clear it with medication and patient pray it works. After the booster patient told my pulmonary doc and PCP that after patient had that booster patient can't breathe. Now the patient know why.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Verbal noises; walking back and forth, jumping, radicals, OCD type behaviors always had some symptoms. Increased on 11/23/09.
patient came to pharmacy to get her second dose. when asked how the first dose was she stated that she had a red area all the way to just above the elbow on the arm that she was given the vaccination. she states that she called her dr's office and was told to put a cold compress on the area and it got better. i called to verify with the dr's office and was told that pt called them on 6/1/2021 and states that she has a red swollen area at the site and was advised to put cold pack on it and take ibuprofen. dr's nurse called back and states that dr advises that it is ok to continue with 2nd dose to just give at a different geographical location
Dizziness, blurred vision, paresthesia's, dropping things, low grade fever, arthralgias, myalgias, chills, and vertigo.
chills, insomnia approximately 14 -16 hours after vaccination,, arm soreness at site starting 4-5 hours after vaccination
Site was moderately swollen and red in day one following immunization. Redness and swelling are significantly worse on day two and the site is warm to the touch. Patient is following up with primary care doctor.
Dizziness; tingling up neck and right-side of face; numbness sensation on right brow, eyelids and cheek/intermittent numbness; headache; This is a spontaneous report from a contactable Other HCP.  A 45-year-old female no pregnant patient received , at hospital , the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from Lot# EL8982 on  21Jan2021 15:15 at SINGLE  DOSE for covid-19 immunisation .  Medical history included diabetes .Concomitant medication included metformin (METFORMIN), glyburide (GLYBURIDE), sitagliptin phosphate (JANUVIA ).The patient previously took codeine and experienced drug hypersensitivity, cortisone and experienced drug hypersensitivity, cortisone and experienced adverse reaction. On 21Jan2021 at 15:30  the patient experienced Dizziness, tingling up neck and rightside of face, numbness sensation on right brow, eyelids and cheek. 2 hours later teeth chattering for hour and half, headache for 4 days, intermittent numbness for 3 days.Outcome of the events was reported as recovered with sequel. No COVID prior vaccination, No COVID tested post vaccination
Information has been received from a physician concerning a 61 year old male patient who on 14-JAN-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# and expiration date not reported) and then on 10-MAR-2011 developed shingles. It was reported that the patient's rash was bilateral and confined to the buttock area. The patient had no pain associated with the rash. The patient visited the office on 29-MAR-2011 for an unrelated issue and physician reported that he is fully recovered. Follow up information has been received from a physician concerning a 61 year old male patient who on 14-JAN-2011 was vaccinated intramuscularly in the left upper extremity with a first dose of ZOSTAVAX (Merck) (Lot# 665310/1195Y and expiration: 24-FEB-2011). Physician stated that the patient had shingles out break (on left buttock, also progress over on right, seen by dermatologist also). It was reported that the patient was evaluated by a dermatologist. At the time of reporting the patient had recovered. Additional information has been requested.
devel swollen glands w/in 24 hrs of vax followed by cough & chest pain;
Day 1: Crushing chest pain and SOB, worse when recumbent and lying on left side. Pain started radiating to left shoulder and scapula.  Day 2: pain stayed the same and also had tachycardia. Went to ER.  EKG had low voltage sinus tachycardia. CXR, WBC nl. CRP elev at 2.3, ESR 12 - high for me. Troponin nl.  Told by ER doc, symptoms due to stress.  Day 3: chest pain etc continued, but developed severe nausea and emesis x 9. Day 4: wife (MD) called CDC medical consultation team to discuss presumptive diagnosis of myopericarditis. Days5-6:  symptoms started to.improve slightly but felt very fatigued and appetite was decreased.  Day 7: appt with cardiologist did echo which was normal but he concurred with ex of pericarditis
Pt presented to our clinic 24 hours after shots were given with extreme fussiness and irritability. Pt was inconsolable and refusing to drink. Screaming was shrill, high pitched concern for meningitis or sepsis. Fever 103. Blood work done. Motrin given pt improved.
I noticed a couple of days after my vaccine that my tongue felt like I had burned it on hot food.   The feeling has changed some. Now it feels as if my tongue is  tingling.  I can taste good, but it tastes odd. I have also noticed that salty foods taste saltier and sweet foods taste sweeter.
Got what appears to be Covid Arm - large red area (approx. 6" in diameter), hot to the touch, itchy, swelling.
Severe swelling, cold sweats, vomiting, finger numbness, point tenderness at site of injection, severe fever for 5 days post injection; followed by 10 day antibiotic treatment which required 13 days before swelling and point tenderness were eliminated.
Large rash around site of injection, extreme nausea, chest pains, headaches, lump in throat, weakness, fever, achy, bruising large lump (welt) at injection site.
Soft ball sized erythema & swelling & fever localized; no gen fever; No aching p/24 hrs; local rxn did not have approx 3 wk gradually diminishing;
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 22-MAY-2015, the patient was vaccinated with improperly stored dose of (Oka/Merck) VARIVASX (lot number, dose and route were unknown). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT REPORTED A RED RASH AT INJECTION SITE AND HIVES ON HER BODY, HAD MORE HIVES ON RIGHT SIDE OF BODY.
p/recv vax pt broke out into hives all around mouth & on forehead & cheeks. given benadryl
Recipeint C/O "scratchy Throat" 20 minutes post 2nd moderna. Only physical finding was some redness of oropharynx with no swelling. At that time she revealed that she had same symptom 1 hour after her first dose for which she took benadry at home with no progression and complete resolution. She was given 50mg Liquid Benadry PO and observed. There was no progression and complete symptom resolution.
Dizziness, Diarrhea, swelling of left arm  Narrative:  Per nursing report: "Called to report took Moderna vaccine on Wednesday [7/28]. C/o diarrhea, dizziness and swelling to left arm. States was off on Thursday but called in today [7/30] due to not feeling well."
arm bruised @ inject site size of quarter for a month, also muscle spasms & stiffness, very painful 29APR93; arm still spasms; MD advised no #2 or 3 dose of vax; MD told pt it was local rxn;
the back of his neck felt itchy/ the itchiness spread all over his body; red welts, and red marks around his ankles that eventually spread all over his body as well; her husband has sensitive skin; dry skin itch; not feeling well; he experienced red blotches; Dates for his legs were peeling and he was just itching all over; This is a spontaneous report from a contactable consumer or other non hcp. A 83-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 04Mar2021 (at the age of 83-year-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced the back of his neck felt itchy/ the itchiness spread all over his body, red welts, and red marks around his ankles that eventually spread all over his body as well, her husband has sensitive skin, dry skin itch, not feeling well, he experienced red blotches, his legs were peeling and he was just itching all over. Reporter wanted to know when her husband will receive his 2nd dose of the vaccine. Patient went to the allergist dermatologist. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
3-16-07 no show for MMR #1 letter mailed to mother. 3-20-07 Here for MMR #1. Pt has red dots from torso down, no fever, just runny nose. This started since receiving her MMR on 3/20/07. Pt had runny nose before receiving shot. Mom was called-rash from head to toe. Little pimples vesicles. Booked tomorrow am at 9 with doctor. Told to go to ER tonight if pt develops breathing problems. 3-22-07 Here with rash after receiving MMR #4. Has improved some since yesterday. Has also developed cough-did have runny nose when received vaccine.
Baby cried thru night after vac. Parents said felt warm to touch. Site without redness or without swelling.
No adverse reactions have occurred.   Patient was expecting the Pfizer Bivalent booster, but was given another dose of mono-valent.  Error occurred due to the nearly identical packaging of both the mono- and bi- valent vaccines, and the lack of a double-check before injection.
Abdominal pain followed by vomiting hives difficulty breathing and itching with mental fog. Had to be given epinephrine - anaphylactic reaction
wanted to file a complain regarding the Moderna covid19 vaccine because  they have had numerous surgeries and etc; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (wanted to file a complain regarding the Moderna covid19 vaccine because  they have had numerous surgeries and etc) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (wanted to file a complain regarding the Moderna covid19 vaccine because  they have had numerous surgeries and etc).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Severe gastrointestinal upset; diarrhea; fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 54-Year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 28Mar2021 at 15:00 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history included atherosclerosis, coronary artery disease, spinal stenosis, obesity, mild chronic obstructive pulmonary disease (COPD) (smoking) and penicillin allergy. Concomitant medications included ibuprofen 800 mg (MANUFACTURER UNKNOWN) and clonazepam (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 29Mar2021 at 04:00, the patient experienced severe gastrointestinal upset, diarrhea and fatigue. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events severe gastrointestinal upset, diarrhea and fatigue. The clinical outcomes of the events severe gastrointestinal upset, diarrhea and fatigue were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Covid; Patient who received the first dose of trumenba last year.  8-6 months after first dose for the second dose; This is a spontaneous report from a Pfizer sponsored program via a contactable Other Healthcare Professional reported for a patient. A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA; Lot number unknown), via an unspecified route of administration on an unspecified date at SINGLE DOSE (first dose) for immunisation. The patient medical history and concomitant medications were not reported. The patient who received the first dose of trumenba a year before (2020). 8-6 months after first dose for the second dose, patient could not get second dose on time due to Covid (as reported). Reporter was inquiring if patient should get second dose or restart process again. Outcome of the event was unknown.  Information on the batch number has been requested.
delayed local reactions; itching (at injection site); Red (at injection site); swollen (at injection site); Aching; This spontaneous case was reported by a consumer and describes the occurrence of LOCAL REACTION (delayed local reactions), VACCINATION SITE PRURITUS (itching (at injection site)), MYALGIA (Aching), VACCINATION SITE ERYTHEMA (Red (at injection site)) and VACCINATION SITE SWELLING (swollen (at injection site)) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included AMLODIPINE BESILATE (NORVASC) and QUINAPRIL for Hypertension, CELECOXIB (CELEBREX) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced MYALGIA (Aching). On 31-Jan-2021, the patient experienced LOCAL REACTION (delayed local reactions), VACCINATION SITE PRURITUS (itching (at injection site)), VACCINATION SITE ERYTHEMA (Red (at injection site)) and VACCINATION SITE SWELLING (swollen (at injection site)). On 26-Jan-2021, MYALGIA (Aching) had resolved. On 02-Feb-2021, LOCAL REACTION (delayed local reactions), VACCINATION SITE PRURITUS (itching (at injection site)), VACCINATION SITE ERYTHEMA (Red (at injection site)) and VACCINATION SITE SWELLING (swollen (at injection site)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not take anything to treat the symptoms.   This case was linked to MOD-2021-205797 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Additional information received On 03-Jun-2021: Duplicate Email, NNI
Patient received influenza vaccine (AP) 11/19.  Patient reported dizziness that started 3 days later and lasted greater than 1 week.
History of patients Pfizer shot vaccine    1/28/21  First Pfizer shot 1/31/21 Rash started with a lot of itching from waste on up on chest, back and arms 2/15/21  Second Pfizer shot 2/18/21  Rash and itching got worst  2/25/21 Seen DR. Prednisone for 10 days. Everything cleared up in two days after starting prednisone  Stopped Prednisone and in 2-3 days rash and itching came back. Took approximately 3-4 more weeks to clear up.  10/07/21  Booster shot of Pfizer   10/09/21  Rash returned to all of upper body as before plus both front and back of legs down to and including top of feet. Much worst than before. 10/15/21  Called Dr office and was prescribed Prednisone, (10 days) rash cleared up in 2-3 days.  10/27/21  rash and itching returned.  12/03/21  Seen  PA. Prednisone for 10 days, Cleared up in 2-3 days. Stopped Prednisone and in 2-3 days rash and itching returned.  12/21/21  online meeting with an, allergist. Said I need to see a dermatologist. He could not help me.  1/13/2022   Seen  dermatologist, prescribed Triamcinolone 0.1% ointment. little relief  Been using otc Benadryl, 1% Hydrocortisone for itching with some relief, Vaseline and Eucerin cream with Vaseline helping the most for my dry skin. Also tried Claritin for itching.  01/07/22  notice rash starting to clear up, especially on legs.
Systemic: Diarrhea-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Additional Details: low blood pressure. was seen by family friend who is a provider. pt came around after having coffee.
She had no reaction. The reason for this report is vaccine was given to a 17 year old, 11 months, and 22 days old, instead of 18 years old as recommended. Upon arrival to our clinic, health history, reviewed and noted no signs or symptoms of distress or allergic/anaphylaxis reaction to any medicine or vaccine in the past. After given Moderna vaccine in left deltoid, Lot# 041B21A, expiration date of 10/04/2021, she waited 20 minutes and in that time, again no adverse reaction or allergic/anaphylaxis noted. After giving her her vaccine card and 20 minute waiting period up. I noted that she was not 18 years old. I informed client and guardian that she is shy of 18 years old and even though she had no adverse reaction/ or anaphylaxis, I still had to write up a report and report it to the proper individuals. Client waited an additional 20 minutes totally 40 minutes and again, no adverse reaction, or anaphylaxis noted. Instructed guardian, grandma, to keep an eye on her for the next 24 hours. She verbalized ok and understanding. Today, July 1, 2021 0900, spoke to guardian and client still has had no adverse or anaphylaxis reaction or any problems noted, but will continue to monitor her.
2 weeks after 2nd moderna vaccine forehead became numb, then within 2 weeks from that the numbness moved down through left  eye,cheek and mouth area - the numbness comes and goes - no changes in cognitive function - still has been occurring occasionally
Pt states had "tunnel vision and feeling of everything fading", ringing of ears and sweating immediately after receiving vaccine. Pt layed down for a few minutes and felt better. No LOC. Refused transport to ER. Father and family who were present took pt home.
Patient verbally requested a FLU shot. We filled and administered a FLU shot. Patient presented back to pharmacy approx 28min later inquiring which shot he received. He said that he wanted the Pneumococcal shot and not the flu shot since he had already received his flu shot earlier in the season.